Sussman, M.; Benner, J.; Mugwagwa, T.; Lee, J.; Hung, S.-T.; Yang, Y.-M.; Chen, Y.
Clinical Benefits of Sustained Oral Nirmatrelvir/Ritonavir Use for the Outpatient Treatment of COVID-19: Findings from the Taiwanese Health Authority Perspective Using a Decision Tree Modeling Approach. J. Mark. Access Health Policy 2024, 12, 326-341.
https://doi.org/10.3390/jmahp12040026
AMA Style
Sussman M, Benner J, Mugwagwa T, Lee J, Hung S-T, Yang Y-M, Chen Y.
Clinical Benefits of Sustained Oral Nirmatrelvir/Ritonavir Use for the Outpatient Treatment of COVID-19: Findings from the Taiwanese Health Authority Perspective Using a Decision Tree Modeling Approach. Journal of Market Access & Health Policy. 2024; 12(4):326-341.
https://doi.org/10.3390/jmahp12040026
Chicago/Turabian Style
Sussman, Matthew, Jennifer Benner, Tendai Mugwagwa, Jackie Lee, Sheng-Tzu Hung, Ya-Min Yang, and Yixi Chen.
2024. "Clinical Benefits of Sustained Oral Nirmatrelvir/Ritonavir Use for the Outpatient Treatment of COVID-19: Findings from the Taiwanese Health Authority Perspective Using a Decision Tree Modeling Approach" Journal of Market Access & Health Policy 12, no. 4: 326-341.
https://doi.org/10.3390/jmahp12040026
APA Style
Sussman, M., Benner, J., Mugwagwa, T., Lee, J., Hung, S.-T., Yang, Y.-M., & Chen, Y.
(2024). Clinical Benefits of Sustained Oral Nirmatrelvir/Ritonavir Use for the Outpatient Treatment of COVID-19: Findings from the Taiwanese Health Authority Perspective Using a Decision Tree Modeling Approach. Journal of Market Access & Health Policy, 12(4), 326-341.
https://doi.org/10.3390/jmahp12040026
